Waltham, MA, United States of America

Bo Peng

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Bo Peng: Innovator in Cancer Treatment

Introduction

Bo Peng is a prominent inventor based in Waltham, MA (US), known for his significant contributions to the field of cancer treatment. With a total of 6 patents to his name, he has made remarkable strides in developing innovative compounds aimed at combating cancer.

Latest Patents

Among his latest patents, Bo Peng has developed MCL-1 inhibitors and methods of use thereof. This patent discloses a compound identified as 17-chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentaazaheptacyclo[27.7.1.10000]octatriaconta-1(37),4(38),6,11,14,16,18,20,23,29,31,33,35-tridecaene-23-carboxylic acid (Formula I) along with its enantiomers and pharmaceutically acceptable salts. The patent also includes pharmaceutical compositions of this compound and methods for treating cancer using these innovative solutions.

Career Highlights

Bo Peng is currently associated with AstraZeneca AB, where he continues to push the boundaries of pharmaceutical research and development. His work focuses on creating effective treatments that can significantly improve patient outcomes in oncology.

Collaborations

He collaborates with notable colleagues, including Alexander Hird and Wenzhan Yang, to further enhance the impact of his research and innovations in the field.

Conclusion

Bo Peng's contributions to cancer treatment through his innovative patents and collaborations highlight his dedication to advancing medical science. His work continues to inspire and pave the way for future breakthroughs in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…